Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Effects of dexamethasone on human skeletal muscle and adipose tissue


ABSTRACT: Context: Glucocorticoids are frequently prescribed drugs with important side-effects such as glucose intolerance and tissue remodelling. Objective: The goal was to explore the molecular basis of the crosstalk between adipose tissue and skeletal muscle during short term glucocorticoid treatment. Design and Intervention: Healthy male subjects were assigned to a 4-d treatment with dexamethasone at 4mg/d. Main Outcome Measures: Primary outcome measures were gene expression profiling of adipose tissue and skeletal muscle. Urinary cortisol and metabolic biochemistry were also assessed. Dexamethasone was provided in 0.5 mg tablets as 4mg per day during 4 days to male healthy volunteers. Skeletal muscle and adipose tissue biopsies were obtained at the beginning and at the end of the protocol. The transcriptome analysis compared before vs. after the 4 days dexamethasone treatment using a dye swap design and whole genome 4x44k oligonucleotide arrays (Agilent Technologies).

ORGANISM(S): Homo sapiens

SUBMITTER: Nathalie Viguerie 

PROVIDER: E-GEOD-17992 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Multiple effects of a short-term dexamethasone treatment in human skeletal muscle and adipose tissue.

Viguerie Nathalie N   Picard Flora F   Hul Gabby G   Roussel Balbine B   Barbe Pierre P   Iacovoni Jason S JS   Valle Carine C   Langin Dominique D   Saris Wim H M WH  

Physiological genomics 20111122 2


Glucocorticoids are frequently prescribed drugs with important side-effects such as glucose intolerance and tissue remodeling. The goal was to explore the molecular basis of the response of skeletal muscle and adipose tissue during a short-term dexamethasone treatment to better understand the induction of side-effects of glucocorticoids on these metabolic tissues. Fifteen healthy male subjects were assigned to a 4-day treatment with dexamethasone at 4 mg/day. The primary outcome measures were ch  ...[more]

Similar Datasets

2010-09-30 | E-GEOD-19494 | biostudies-arrayexpress
2012-12-10 | E-GEOD-40551 | biostudies-arrayexpress
2010-05-19 | E-GEOD-9805 | biostudies-arrayexpress
2011-11-03 | E-TABM-1095 | biostudies-arrayexpress
2010-06-05 | E-GEOD-1373 | biostudies-arrayexpress
2010-06-10 | E-GEOD-2488 | biostudies-arrayexpress
2015-01-15 | E-GEOD-46221 | biostudies-arrayexpress
2006-03-29 | E-GEOD-4497 | biostudies-arrayexpress
2014-11-06 | E-GEOD-48872 | biostudies-arrayexpress
2010-07-27 | E-GEOD-23168 | biostudies-arrayexpress